Marizyme develops targeted biopharmaceutical therapies to improve treatment outcomes for various medical conditions. The company utilizes advanced drug delivery systems and precision medicine techniques to provide effective alternatives to existing therapies.
Funding
$5.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many medical conditions lack effective treatments, leading to suboptimal patient outcomes. Existing therapies may have limitations in terms of efficacy, delivery, or patient tolerability.
Solution
Marizyme is a biomedical company focused on developing and commercializing medical technologies to improve patient health outcomes. The company leverages multiple technology platforms to create targeted biopharmaceutical therapies. These therapies aim to provide effective alternatives to existing treatments for a range of medical conditions.
Target Audience
The primary target audience includes patients with medical conditions that have limited or ineffective treatment options, as well as healthcare providers seeking improved therapeutic solutions.
Features
- Development of targeted biopharmaceutical therapies
- Utilization of advanced drug delivery systems
- Application of precision medicine techniques